The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s.
Ro said nearly half of the company's patients have some form of insurance coverage for a GLP-1, according to its customer data.
Ro said it hopes its new tool can help patients understand their coverage options so they can decide how to pursue weight loss.
The digital health company may benefit too, as it could drive some patients to join the company's GLP-1 program.
It includes 24/7 messaging, one-on-one coaching with nurses and help with navigating insurance coverage.
Persons:
Ro, Zachariah Reitano
Organizations:
Novo Nordisk, CNBC
Locations:
U.S